Microbiome Diagnostics
A Global Strategic Business Report
MCP32136
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Microbiome Diagnostics Market to Reach US$334.1 Million by 2030
The global market for Microbiome Diagnostics estimated at US$157.4 Million in the year 2024, is expected to reach US$334.1 Million by 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Microbiome Diagnostic Kits & Reagents, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$229.9 Million by the end of the analysis period. Growth in the Microbiome Diagnostic Instruments segment is estimated at 9.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$42.9 Million While China is Forecast to Grow at 18.2% CAGR
The Microbiome Diagnostics market in the U.S. is estimated at US$42.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$72.1 Million by the year 2030 trailing a CAGR of 18.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.6% and 12.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.
Global Microbiome Diagnostics Market – Key Trends & Drivers Summarized
What Are Microbiome Diagnostics and How Do They Impact Healthcare?
Microbiome diagnostics refer to the testing and analysis of the human microbiome, which comprises the trillions of microorganisms (bacteria, fungi, viruses, and archaea) that live in and on the human body, primarily in the gut. These microorganisms play a crucial role in maintaining overall health, influencing immune function, metabolism, and even mental health. Microbiome diagnostics involve identifying, characterizing, and monitoring these microbial communities, often through advanced sequencing technologies and bioinformatics. The insights derived from these diagnostics have the potential to transform personalized medicine, offering a more targeted approach to healthcare based on an individual’s microbiome composition.
Microbiome diagnostics typically employ techniques like 16S rRNA gene sequencing, metagenomic sequencing, and shotgun sequencing to map out microbial diversity and identify specific microbial species present in a patient. By understanding the composition of the microbiome, researchers and healthcare providers can identify imbalances or dysbiosis, which is associated with a range of health conditions, including gastrointestinal disorders, autoimmune diseases, obesity, diabetes, and even neurological conditions like depression and anxiety. The potential to treat or manage these conditions by restoring microbial balance is driving the growing interest and investment in microbiome diagnostics.
Microbiome diagnostics also have applications in monitoring disease progression, determining the effectiveness of treatments, and predicting disease risk. As researchers continue to explore the complex relationship between the microbiome and health, diagnostics tools will enable clinicians to identify biomarkers for various diseases, improving early detection and facilitating precision medicine. As such, microbiome diagnostics represent a paradigm shift in healthcare, offering a more holistic and personalized approach to disease management and prevention.
What Are the Key Trends Shaping the Microbiome Diagnostics Market?
A major trend influencing the microbiome diagnostics market is the growing emphasis on personalized and precision medicine. Traditional diagnostic methods are often generalized and may not account for individual differences in microbial communities. In contrast, microbiome diagnostics allow for highly personalized insights into a person’s health, identifying microbial imbalances that could influence their risk of diseases such as cancer, diabetes, and irritable bowel syndrome (IBS). As precision medicine becomes more prevalent, microbiome diagnostics are expected to play an integral role in tailoring therapies to the unique microbiological profile of each patient.
Another important trend is the increasing use of microbiome-based therapeutics, such as probiotics, prebiotics, and microbiome transplants. These therapies aim to restore a healthy microbial balance in the body and are gaining traction due to their potential to treat a variety of conditions, from gastrointestinal issues to mental health disorders. As the microbiome is increasingly recognized as an integral part of human health, diagnostics tools that help identify microbial imbalances are becoming critical for determining the most appropriate therapeutic interventions. The development of microbiome-based therapeutics is closely tied to advances in microbiome diagnostics, making these technologies essential for both researchers and clinicians working in the field of microbiome medicine.
The integration of artificial intelligence (AI) and machine learning (ML) in microbiome diagnostics is another key trend. AI and ML technologies are enabling the analysis of complex microbiome data, which can be highly intricate and multidimensional. These advanced technologies can identify hidden patterns and correlations between microbial composition and health outcomes, improving the accuracy and predictive power of microbiome diagnostics. AI-powered algorithms are also being used to analyze large datasets from clinical trials, providing valuable insights into how microbial communities influence disease progression and treatment response. As a result, AI and ML are expected to play an increasingly important role in advancing the capabilities and applications of microbiome diagnostics.
How Are Microbiome Diagnostics Benefiting Healthcare and Disease Management?
Microbiome diagnostics are transforming healthcare by enabling more accurate disease detection, personalized treatment plans, and better patient outcomes. One of the most prominent applications is in gastrointestinal disorders. Conditions like IBS, Crohn’s disease, and ulcerative colitis are strongly linked to microbial imbalances in the gut, and traditional diagnostic methods often fail to identify the underlying microbial causes. Microbiome diagnostics can provide a clearer understanding of these disorders by analyzing gut microbiota composition, which can help in diagnosing these conditions more accurately and monitoring their progression.
In addition to gastrointestinal conditions, microbiome diagnostics have shown promise in addressing metabolic diseases like obesity, type 2 diabetes, and cardiovascular disease. Research has shown that the gut microbiome plays a significant role in regulating metabolism, insulin sensitivity, and fat storage. By identifying specific microbial species or microbial patterns associated with metabolic conditions, microbiome diagnostics can assist in early detection and help monitor the effectiveness of dietary or pharmaceutical interventions. Furthermore, microbiome diagnostics can identify microbial biomarkers for chronic diseases, enabling clinicians to track disease progression and customize treatments accordingly.
Microbiome diagnostics are also being explored for their potential in cancer treatment. Recent studies suggest that the microbiome may influence the efficacy of cancer therapies, including chemotherapy and immunotherapy. For example, certain gut microbiota have been found to enhance the effectiveness of immune checkpoint inhibitors in cancer treatment. By identifying specific microbial compositions in cancer patients, microbiome diagnostics may help predict which patients are more likely to respond to certain treatments, thereby improving treatment outcomes. This approach could ultimately lead to more targeted cancer therapies and better survival rates for patients.
What Are the Key Growth Drivers in the Microbiome Diagnostics Market?
The growth in the microbiome diagnostics market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in genomic sequencing technologies, and the growing focus on personalized healthcare. As chronic diseases such as obesity, diabetes, and gastrointestinal disorders continue to rise worldwide, there is a growing need for diagnostic tools that can offer deeper insights into their underlying causes. Microbiome diagnostics address this need by enabling more precise detection of microbial imbalances that contribute to the onset and progression of these diseases, leading to earlier intervention and more effective management.
Advancements in genomic sequencing technologies are another major growth driver. The development of high-throughput sequencing techniques, such as next-generation sequencing (NGS), has drastically reduced the cost and time required to sequence microbial genomes, making microbiome analysis more accessible and cost-effective. As sequencing technology improves, microbiome diagnostics are becoming more accurate and capable of identifying a broader range of microbial species. This has enabled the development of more comprehensive diagnostic tests that can be used in clinical settings to provide actionable insights into a patient’s health.
The growing emphasis on personalized medicine is also a significant factor propelling the market. As healthcare shifts toward individualized treatment plans based on genetic, environmental, and lifestyle factors, microbiome diagnostics are playing a key role in offering more personalized healthcare solutions. By providing a detailed analysis of a patient’s microbiome, healthcare providers can develop tailored treatment regimens that are better suited to the patient’s unique microbial profile. This approach is especially beneficial in areas such as oncology, where personalized therapies are critical for improving patient outcomes.
In addition, increasing investments in microbiome research are accelerating the development of new diagnostic tools and therapeutics. Government agencies, private companies, and research institutions are investing heavily in microbiome research to explore its potential for treating a wide range of diseases. This surge in research is leading to the discovery of new biomarkers and the development of novel diagnostic platforms, further fueling the growth of the microbiome diagnostics market. With the increasing recognition of the microbiome’s importance in human health, the market is expected to continue expanding rapidly, offering new opportunities for diagnostics companies, healthcare providers, and patients alike.
In conclusion, the microbiome diagnostics market is experiencing robust growth driven by advancements in sequencing technologies, the rise of personalized medicine, and the growing demand for precise disease management tools. As our understanding of the microbiome deepens and its role in human health becomes more recognized, microbiome diagnostics are poised to become a cornerstone of healthcare. The ability to analyze and manipulate the microbiome will not only improve disease detection but also pave the way for novel treatments and more effective prevention strategies, transforming healthcare as we know it.
SCOPE OF STUDY
The report analyzes the Microbiome Diagnostics market by the following Segments, and Geographic Regions/Countries:
Segments:
Product Type (Microbiome Diagnostic Kits & Reagents, Microbiome Diagnostic Instruments); Technology (16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology, Other Technologies); Sample Type (Fecal Samples, Saliva Samples, Skin Samples, Other Sample Types); Application (Disease Diagnostic Application, Research Applications); End-Use (Hospitals End-Use, Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
Alba Health; Axial Biotherapeutics; Beo Therapeutics; BioMed Technology Holdings; bioMérieux; Daye; Evelo Biosciences; Extension Health; Function Health; Microba; Nexilico; Ombre; Pendulum Therapeutics; Rebiotix Inc.; Seres Therapeutics; Siolta Therapeutics; Sun Genomics; Vedanta Biosciences; Viavi
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Microbiome Diagnostics – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 44 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Focus on Personalized Medicine Throws the Spotlight on Microbiome-Based Diagnostic Solutions |
| Growing Awareness of Gut-Brain Axis Expands Addressable Market Opportunity for Neurological Microbiome Diagnostics |
| Increasing Burden of Chronic Diseases Spurs Adoption of Microbiome Testing in Preventive Healthcare |
| Integration of Artificial Intelligence in Microbiome Analysis Accelerates Diagnostic Accuracy and Market Penetration |
| Advancements in Next-Generation Sequencing (NGS) Propel Growth of High-Resolution Microbiome Diagnostics |
| Increasing Emphasis on Holistic Health and Wellness Drives Demand for Gut Microbiome Screening Services |
| Rising Investments in Microbiome Startups Strengthens the Business Case for Commercial Diagnostic Platforms |
| Expanding Applications of Microbiome Testing in Oncology Generates New Revenue Streams and Demand |
| Government and Academic Funding Initiatives Sustain Growth Momentum for Microbiome Research and Diagnostics |
| Growing Clinical Evidence Base Validating Microbiome Biomarkers Strengthens Confidence in Diagnostic Accuracy |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Microbiome Diagnostics Market Analysis of Annual Sales in US$ for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Microbiome Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Microbiome Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Microbiome Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Microbiome Diagnostic Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Microbiome Diagnostic Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Microbiome Diagnostic Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Microbiome Diagnostic Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Microbiome Diagnostic Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Microbiome Diagnostic Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Fecal Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Fecal Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Fecal Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Saliva Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Saliva Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Saliva Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Skin Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Skin Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Skin Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Disease Diagnostic Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Disease Diagnostic Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Disease Diagnostic Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Research Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Research Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Research Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for 16S rRNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for 16S rRNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for 16S rRNA Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Shotgun Metagenomics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Shotgun Metagenomics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Shotgun Metagenomics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Metatranscriptomics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Metatranscriptomics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Metatranscriptomics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| JAPAN |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| CHINA |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| EUROPE |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Microbiome Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Microbiome Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| FRANCE |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| GERMANY |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Microbiome Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| INDIA |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Microbiome Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Microbiome Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Microbiome Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Microbiome Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
| AFRICA |
| Microbiome Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Microbiome Diagnostics by Product Type - Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Microbiome Diagnostics by Product Type - Percentage Breakdown of Value Sales for Microbiome Diagnostic Kits & Reagents and Microbiome Diagnostic Instruments for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Microbiome Diagnostics by Sample Type - Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Microbiome Diagnostics by Sample Type - Percentage Breakdown of Value Sales for Other Sample Types, Fecal Samples, Saliva Samples and Skin Samples for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Microbiome Diagnostics by Application - Disease Diagnostic Application and Research Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Microbiome Diagnostics by Application - Percentage Breakdown of Value Sales for Disease Diagnostic Application and Research Applications for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Microbiome Diagnostics by End-Use - Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Microbiome Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Academic & Research Institutes End-Use and Pharma & Biotech Companies End-Use for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Microbiome Diagnostics by Technology - 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Microbiome Diagnostics by Technology - Percentage Breakdown of Value Sales for 16S rRNA Sequencing Technology, Shotgun Metagenomics Technology, Metatranscriptomics Technology and Other Technologies for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]